Tech Company Financing Transactions
Terapio Funding Round
Terapio, operating out of Austin, secured $5 million from Sante Ventures.
Transaction Overview
Company Name
Announced On
11/30/2009
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Sante Ventures (Kevin Lalande)
Proceeds Purpose
Proceeds from this financing will be used to continue preclinical development of the radiation countermeasure and drug delivery applications and to prepare an Investigational New Drug (IND) Application with the FDA to begin human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
401 Congress 2950
Austin, TX 78701
USA
Austin, TX 78701
USA
Phone
Website
Email Address
Overview
Terapio is developing a pipeline of therapies based on the normally-occurring transport protein RLIP76 that moves free-radical toxins out of cells before significant damage can occur.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Curt Bilby
Chief Medical Officer
Casey Cunningham
VP - Bus. Development
Henry Hebel
Browse more venture capital transactions:
Prev: 11/30/2009: Interactive Advisory Software venture capital transaction
Next: 11/30/2009: Panraven venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs